Patents by Inventor Anthony D. Sercel

Anthony D. Sercel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7144995
    Abstract: A fluorescent nitrogenous base and nucleosides including the fluorescent nitrogenous base are provided. Nucleosides including the fluorescent nitrogenous base are capable of Watson-Crick base pairing with naturally occurring nucleosides. The nucleosides including the fluorescent nitrogenous base have many uses including but not limited to use in probes, in the synthesis of nucleic acids, and in investigating nucleic acid interactions with other nucleic acids and/or with proteins.
    Type: Grant
    Filed: March 6, 2003
    Date of Patent: December 5, 2006
    Assignees: Glen Research Corporation, Berry & Associates
    Inventors: Dean S. Wise, Anthony D. Sercel, Kee-Yong Jung, David A. Berry, John B. Randolph, Robert L. Somers, Hugh Mackie
  • Publication number: 20040009933
    Abstract: A fluorescent nitrogenous base and nucleosides including the fluorescent nitrogenous base are provided. Nucleosides including the fluorescent nitrogenous base are capable of Watson-Crick base pairing with naturally occurring nucleosides. The nucleosides including the fluorescent nitrogenous base have many uses including but not limited to use in probes, in the synthesis of nucleic acids, and in investigating nucleic acid interactions with other nucleic acids and/or with proteins.
    Type: Application
    Filed: March 6, 2003
    Publication date: January 15, 2004
    Applicants: Glen Research Corporation, Berry & Associates
    Inventors: Dean S. Wise, Anthony D. Sercel, Kee-Yong Jung, David A. Berry, John B. Randolph, Robert L. Somers, Hugh Mackie
  • Patent number: 5543527
    Abstract: Chiral compounds useful as radiosensitizers or chemosensitizers having the formula ##STR1## wherein X is halogen or ##STR2## intermediates used to prepare these compounds, and a novel process to prepare these compounds are described.
    Type: Grant
    Filed: May 18, 1995
    Date of Patent: August 6, 1996
    Assignees: British Technoloyg Group Limited, Warner-Lambert Company
    Inventors: Vladimir G. Beylin, Anthony D. Sercel, Howard D. H. Showalter, Gerald E. Adams, Edward M. Fielden, Matthew A. Naylor, Ian J. Stratford
  • Patent number: 5481000
    Abstract: Chiral compounds useful as radiosensitizers or chemosensitizers having the formula ##STR1## wherein X is halogen or ##STR2## intermediates used to prepare these compounds, and a novel process to prepare these compounds are described.
    Type: Grant
    Filed: December 19, 1994
    Date of Patent: January 2, 1996
    Assignee: Warner-Lambert Company
    Inventors: Vladimir G. Beylin, Anthony D. Sercel, Howard D. H. Showalter, Gerald E. Adams, Edward M. Fielden, Matthew A. Naylor, Ian J. Stratford
  • Patent number: 5342959
    Abstract: Chiral compounds useful as radiosensitizers or chemosensitizers having the formula ##STR1## wherein X is halogen or ##STR2## intermediates used to prepare these compounds, and a novel process to prepare these compounds are described.
    Type: Grant
    Filed: August 5, 1993
    Date of Patent: August 30, 1994
    Assignees: Warner-Lambert Company, British Tech. Group
    Inventors: Vladimir Genukh Beylin, Anthony D. Sercel, Howard D. H. Showalter, Gerald E. Adams, Edward M. Fielden, Matthew A. Naylor, Ian J. Stratford
  • Patent number: 4806654
    Abstract: Improved processes for producing substituted benzo(chalcogeno)[4,3,2-cd] indazoles. The processes produce compounds in higher yields and of greater purity by using a novel sequence of acylation chemistry and easily removed protecting groups. The compounds produced have antibacterial, antifungal, antileukemic, and antitumor activity.
    Type: Grant
    Filed: February 11, 1988
    Date of Patent: February 21, 1989
    Assignee: Warner-Lambert Company
    Inventors: Vladimir G. Beylin, Om P. Goel, Anthony D. Sercel, Howard D. H. Showalter
  • Patent number: 4604390
    Abstract: Substituted 2H-[1]benzopyrano[4,3,2-cd]indazoles, 2H-[1]benzothiopyrano[4,3,2-cd]indazoles, and 2H-[1]benzoselenino[4,3,2-cd]indazoles have demonstrated pharmacological activity against a broad spectrum of Gram-positive and Gram-negative bacteria, yeasts, and fungi, as well as activity against the L1210 and P388 murine leukemia cells lines.Pharmaceutical compositions containing the compounds and methods of employing the compounds in methods of treating bacterial or fungal infections and of inhibiting the growth of neoplasms in mammals are also disclosed.
    Type: Grant
    Filed: May 24, 1985
    Date of Patent: August 5, 1986
    Assignee: Warner-Lambert Company
    Inventors: Edward F. Elslager, Leslie M. Werbel, Daniel F. Ortwine, Donald F. Worth, Howard D. H. Showalter, David B. Capps, Ellen M. Berman, Vlad E. Gregor, Anthony D. Sercel